JFG
ONC

Jefferies Financial Group’s BeOne Medicines Ltd ONC Stock Holding History

Jefferies Financial Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,800
Closed -$4.45M – 1918
2024
Q3 		$4.45M Buy
+19,800
New +$3.56M 0.03% 345

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jefferies Financial Group's ONC Position: Q1 2026 in Review

Jefferies Financial Group held its BeOne Medicines Ltd (ONC) position steady in Q1 2026 at 6,200 shares worth $1.84M. The position accounts for 0.01% of the portfolio, ranked #671.

Jefferies Financial Group first reported a position in ONC in Q3 2023 and has held it in 8 quarters since. The position peaked at $8.3M in Q4 2023. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Jefferies Financial Group held 6,200 shares of BeOne Medicines Ltd worth $1.84M as of Q1 2026.
  • Jefferies Financial Group left its BeOne Medicines Ltd share count unchanged in Q1 2026.
  • BeOne Medicines Ltd made up 0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #671 holding.
  • Jefferies Financial Group first reported a position in BeOne Medicines Ltd in Q3 2023 and has held it in 8 quarters since.
  • Jefferies Financial Group's BeOne Medicines Ltd position peaked at $8.3M in Q4 2023.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.